MAVIRET 50 MG/20 MG GRANULOS RECUBIERTOS EN SOBRE
MAVIRET 50 MG/20 MG GRANULOS RECUBIERTOS EN SOBRE
Commercialized
Register Number
1171213002
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Dec 23, 2021
Dosage Form
GRANULOS RECUBIERTOS EN SOBRES
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1171213002
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
GLECAPREVIRActive
Quantity: 50 mg
Name: GLECAPREVIR
PIBRENTASVIRActive
Quantity: 20 mg
Name: PIBRENTASVIR
ATC CLASSIFICATION (3)
J05A
J05AP
J05AP57